http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0039294-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0cb7734bc2e5840db630f0ae7c29684
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76
filingDate 1981-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd95ce471492c7aec2dc84cbacc2ab4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24964d634471cce6a4b54f371c6067b3
publicationDate 1981-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0039294-A1
titleOfInvention Bis-(substituted phenoxyacetates) of N-alkyl-dialkanol amines, process for their preparation, and pharmaceutical compositions containing them
abstract The invention relates to bis (substituted phenoxyacetates) of N-alkyl dialkanolamines.n n n X est le chlore, le fluor ou le trifluorométhyle, n est compris entre 1 et 3 et est de préférence égal à 2, R est un groupe alkyle inférieur,tel que le groupe méthyle ou éthyle et les sels pharmaceutiquement acceptables desdits composés. These compounds correspond to the formula: in which: X is chlorine, fluorine or trifluoromethyl, n is between 1 and 3 and is preferably equal to 2, R is a lower alkyl group, such as the methyl group or ethyl and the pharmaceutically acceptable salts of said compounds. n n n Application: prevention and treatment of brain disorders.
priorityDate 1980-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2771477-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2085634-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128469775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1991430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129443877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129173268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129326574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2841573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228573670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226513312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18003851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70513604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236325675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129764505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129264553

Total number of triples: 47.